申请人:Singh Chandan
公开号:US20070191475A1
公开(公告)日:2007-08-16
The present invention relates to spiro 1,2,4-trioxanes of general formula 4. This invention more particularly relates to a process for the preparation of a series of spiro 1,2,4-trioxanes.
Wherein, Ar represents aryl groups such as phenyl, 4-biphenyl, 4-chlorophenyl, 4-methoxyphenyl, 4-methylphenyl, 4-cyclohexylphenyl, 1-naphthyl, 2-naphthyl and the like and R represents hydrogen or the alkyl group such as methyl, ethyl and the like. Several of these compounds show high order of antimalarial activity against multidrug-resistant malaria in mice and thus hold promise as antimalarial agents against multidrug-resistant malaria.
本发明涉及一般式4的螺环1,2,4-三氧杂环丙烷。该发明更具体地涉及一种制备一系列螺环1,2,4-三氧杂环丙烷的方法。其中,Ar代表芳基团,如苯基、4-联苯基、4-氯苯基、4-甲氧基苯基、4-甲基苯基、4-环己基苯基、1-萘基、2-萘基等,R代表氢或烷基,如甲基、乙基等。这些化合物中的几种显示出高度的抗疟活性,对多药耐药性疟疾在小鼠中具有作用,并因此有望作为抗多药耐药性疟疾的抗疟药物。